2997 Corticosteroid dose tapering in patients with generalised myasthenia gravis on zilucoplan: interim analysis of RAISE-XT

• M Isabel Leite,
• Channa Hewamadduma,
• Miriam Freimer,
• James F Howard,
• Angela Genge,
• Babak Boroojerdi,
• Lauren Marchio,
• Raphaëlle Beau Lejdstrom,
• Fiona Grimson,
• Natasa Savic

Affiliations

M Isabel Leite

6Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK

Channa Hewamadduma

4Academic Neuroscience Unit, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK

Miriam Freimer

Department of Neurology, Ohio State University Medical Center, Columbus, Ohio, USA

James F Howard

14Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Angela Genge

1Clinical Research Unit, The Montreal Neurological Institute, Montreal, Quebec, Canada

Babak Boroojerdi

9UCB Pharma, Monheim, Germany

Lauren Marchio

1UCB Pharma, Malvern, VIC, Australia

Raphaëlle Beau Lejdstrom

7UCB Pharma, Bulle, Switzerland

Fiona Grimson

9UCB Pharma, Slough, UK

Natasa Savic

7UCB Pharma, Bulle, Switzerland